Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

56.56
Delayed Data
As of Sep 25
 -0.13 / -0.23%
Today’s Change
41.38
Today|||52-Week Range
57.93
+15.52%
Year-to-Date
No recent news for Anika Therapeutics Inc.

Today’s Trading

Previous close56.69
Today’s open56.59
Day’s range56.16 - 57.29
Volume87,620
Average volume (3 months)97,876
Market cap$831.0M
Dividend yield--
Data as of 09/25/2017

Growth & Valuation

Earnings growth (last year)+6.97%
Earnings growth (this year)-7.29%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+11.16%
P/E ratio25.1
Price/Sales7.16
Price/Book3.72

Competitors

 Today’s
change
Today’s
% change
ATRCAtriCure Inc-0.02-0.09%
LMNXLuminex Corp+0.17+0.85%
CRYCryoLife Inc-0.20-0.92%
LMATLeMaitre Vascular In...-0.28-0.75%
Data as of 4:02pm ET, 09/25/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$0.44
Annual revenue (last year)$103.4M
Annual profit (last year)$32.5M
Net profit margin31.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Charles H. Sherwood
President
Joseph G. Darling
Corporate headquarters
Bedford, Massachusetts

Forecasts